
Kauser M. Akhoon
Examiner (ID: 6812, Phone: (571)270-1026 , Office: P/1642 )
| Most Active Art Unit | 1642 |
| Art Unit(s) | 1642, 1613 |
| Total Applications | 267 |
| Issued Applications | 151 |
| Pending Applications | 2 |
| Abandoned Applications | 116 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10784143
[patent_doc_number] => 20160130299
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-12
[patent_title] => 'TUBULYSIN ANALOGS AND METHODS OF MAKING AND USE'
[patent_app_type] => utility
[patent_app_number] => 14/833422
[patent_app_country] => US
[patent_app_date] => 2015-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 30511
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14833422
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/833422 | Tubulysin analogs and methods of making and use | Aug 23, 2015 | Issued |
Array
(
[id] => 10700566
[patent_doc_number] => 20160046711
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-02-18
[patent_title] => 'ANTI-CDH6 ANTIBODY DRUG CONJUGATES'
[patent_app_type] => utility
[patent_app_number] => 14/820897
[patent_app_country] => US
[patent_app_date] => 2015-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 68151
[patent_no_of_claims] => 61
[patent_no_of_ind_claims] => 31
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14820897
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/820897 | Anti-CDH6 antibody drug conjugates | Aug 6, 2015 | Issued |
Array
(
[id] => 13105079
[patent_doc_number] => 10071168
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-09-11
[patent_title] => Polyoxazoline antibody drug conjugates
[patent_app_type] => utility
[patent_app_number] => 14/815718
[patent_app_country] => US
[patent_app_date] => 2015-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 24827
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 118
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14815718
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/815718 | Polyoxazoline antibody drug conjugates | Jul 30, 2015 | Issued |
Array
(
[id] => 11296766
[patent_doc_number] => 09504758
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-11-29
[patent_title] => 'Modified antibody, antibody-conjugate and process for the preparation thereof'
[patent_app_type] => utility
[patent_app_number] => 14/807503
[patent_app_country] => US
[patent_app_date] => 2015-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 41
[patent_no_of_words] => 35776
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14807503
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/807503 | Modified antibody, antibody-conjugate and process for the preparation thereof | Jul 22, 2015 | Issued |
Array
(
[id] => 11857948
[patent_doc_number] => 09737616
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-08-22
[patent_title] => 'Compounds and methods for the treatment of ERB B2/NEU positive diseases'
[patent_app_type] => utility
[patent_app_number] => 14/802900
[patent_app_country] => US
[patent_app_date] => 2015-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 10
[patent_no_of_words] => 13639
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14802900
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/802900 | Compounds and methods for the treatment of ERB B2/NEU positive diseases | Jul 16, 2015 | Issued |
Array
(
[id] => 11275920
[patent_doc_number] => 09492391
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-11-15
[patent_title] => 'Tamper resistant dosage forms'
[patent_app_type] => utility
[patent_app_number] => 14/729626
[patent_app_country] => US
[patent_app_date] => 2015-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 43
[patent_no_of_words] => 66052
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 247
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14729626
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/729626 | Tamper resistant dosage forms | Jun 2, 2015 | Issued |
Array
(
[id] => 10380593
[patent_doc_number] => 20150265600
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-24
[patent_title] => 'TAMPER RESISTANT DOSAGE FORMS'
[patent_app_type] => utility
[patent_app_number] => 14/729660
[patent_app_country] => US
[patent_app_date] => 2015-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 66008
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14729660
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/729660 | Tamper resistant dosage forms | Jun 2, 2015 | Issued |
Array
(
[id] => 11262131
[patent_doc_number] => 09486412
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-11-08
[patent_title] => 'Tamper resistant dosage forms'
[patent_app_type] => utility
[patent_app_number] => 14/729593
[patent_app_country] => US
[patent_app_date] => 2015-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 43
[patent_no_of_words] => 66124
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14729593
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/729593 | Tamper resistant dosage forms | Jun 2, 2015 | Issued |
Array
(
[id] => 11804423
[patent_doc_number] => 09545380
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-01-17
[patent_title] => 'Tamper resistant dosage forms'
[patent_app_type] => utility
[patent_app_number] => 14/729688
[patent_app_country] => US
[patent_app_date] => 2015-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 43
[patent_no_of_words] => 66062
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 238
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14729688
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/729688 | Tamper resistant dosage forms | Jun 2, 2015 | Issued |
Array
(
[id] => 11275918
[patent_doc_number] => 09492389
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-11-15
[patent_title] => 'Tamper resistant dosage forms'
[patent_app_type] => utility
[patent_app_number] => 14/729565
[patent_app_country] => US
[patent_app_date] => 2015-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 43
[patent_no_of_words] => 66067
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 167
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14729565
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/729565 | Tamper resistant dosage forms | Jun 2, 2015 | Issued |
Array
(
[id] => 11275919
[patent_doc_number] => 09492390
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-11-15
[patent_title] => 'Tamper resistant dosage forms'
[patent_app_type] => utility
[patent_app_number] => 14/729601
[patent_app_country] => US
[patent_app_date] => 2015-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 43
[patent_no_of_words] => 66045
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14729601
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/729601 | Tamper resistant dosage forms | Jun 2, 2015 | Issued |
Array
(
[id] => 10380599
[patent_doc_number] => 20150265601
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-24
[patent_title] => 'TAMPER RESISTANT DOSAGE FORMS'
[patent_app_type] => utility
[patent_app_number] => 14/729675
[patent_app_country] => US
[patent_app_date] => 2015-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 65943
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14729675
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/729675 | Tamper resistant dosage forms | Jun 2, 2015 | Issued |
Array
(
[id] => 10380592
[patent_doc_number] => 20150265599
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-24
[patent_title] => 'TAMPER RESISTANT DOSAGE FORMS'
[patent_app_type] => utility
[patent_app_number] => 14/729634
[patent_app_country] => US
[patent_app_date] => 2015-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 65988
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14729634
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/729634 | Tamper resistant dosage forms | Jun 2, 2015 | Issued |
Array
(
[id] => 10760564
[patent_doc_number] => 20160106716
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-04-21
[patent_title] => 'Solid Dosage Forms of Bendamustine'
[patent_app_type] => utility
[patent_app_number] => 14/717743
[patent_app_country] => US
[patent_app_date] => 2015-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 20586
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14717743
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/717743 | Solid Dosage Forms of Bendamustine | May 19, 2015 | Abandoned |
Array
(
[id] => 16105573
[patent_doc_number] => 10695371
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-06-30
[patent_title] => Modification of extracorporeal photopherisis technology with porphyrin precursors
[patent_app_type] => utility
[patent_app_number] => 15/306442
[patent_app_country] => US
[patent_app_date] => 2015-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 17
[patent_no_of_words] => 13602
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15306442
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/306442 | Modification of extracorporeal photopherisis technology with porphyrin precursors | Apr 23, 2015 | Issued |
Array
(
[id] => 11713682
[patent_doc_number] => 20170182181
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-29
[patent_title] => 'PHOSPHATE BASED LINKERS FOR INTRACELLULAR DELIVERY OF DRUG CONJUGATES'
[patent_app_type] => utility
[patent_app_number] => 15/301564
[patent_app_country] => US
[patent_app_date] => 2015-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 38940
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15301564
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/301564 | Phosphate based linkers for intracellular delivery of drug conjugates | Mar 29, 2015 | Issued |
Array
(
[id] => 10627644
[patent_doc_number] => 09345783
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-05-24
[patent_title] => 'Immunoconjugates with an intracellularly-cleavable linkage'
[patent_app_type] => utility
[patent_app_number] => 14/636790
[patent_app_country] => US
[patent_app_date] => 2015-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 27974
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14636790
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/636790 | Immunoconjugates with an intracellularly-cleavable linkage | Mar 2, 2015 | Issued |
Array
(
[id] => 11419935
[patent_doc_number] => 20170028079
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-02
[patent_title] => 'Compounds and Compositions for Treating HER2 Positive Tumors'
[patent_app_type] => utility
[patent_app_number] => 15/110679
[patent_app_country] => US
[patent_app_date] => 2015-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 32627
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15110679
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/110679 | Compounds and Compositions for Treating HER2 Positive Tumors | Jan 7, 2015 | Abandoned |
Array
(
[id] => 13672829
[patent_doc_number] => 20160375148
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-29
[patent_title] => Compounds and Compositions for Treating EGFR Expressing Tumors
[patent_app_type] => utility
[patent_app_number] => 15/110690
[patent_app_country] => US
[patent_app_date] => 2015-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26638
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15110690
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/110690 | Compounds and compositions for treating EGFR expressing tumors | Jan 7, 2015 | Issued |
Array
(
[id] => 15383773
[patent_doc_number] => 10533058
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-01-14
[patent_title] => Peptidomimetic compounds and antibody-drug conjugates thereof
[patent_app_type] => utility
[patent_app_number] => 15/104388
[patent_app_country] => US
[patent_app_date] => 2014-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 30615
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 365
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15104388
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/104388 | Peptidomimetic compounds and antibody-drug conjugates thereof | Dec 15, 2014 | Issued |